| pubmed-article:2446889 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2446889 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:2446889 | lifeskim:mentions | umls-concept:C0005682 | lld:lifeskim |
| pubmed-article:2446889 | lifeskim:mentions | umls-concept:C0027793 | lld:lifeskim |
| pubmed-article:2446889 | lifeskim:mentions | umls-concept:C0060993 | lld:lifeskim |
| pubmed-article:2446889 | lifeskim:mentions | umls-concept:C1709060 | lld:lifeskim |
| pubmed-article:2446889 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:2446889 | pubmed:dateCreated | 1988-2-2 | lld:pubmed |
| pubmed-article:2446889 | pubmed:abstractText | Galanin (GAL) produced a concentration (0.3-100 nM)-related inhibition of the atropine-sensitive component of the contractions induced by field stimulation of detrusor strips from the dome of the human urinary bladder. GAL had an ED50 of 2 nM for the inhibition. The effect of GAL was prevented by atropine (1 microM) and was not seen when the strips were stimulated with a cholinomimetic or KCl. These data suggest a possible neuromodulator role of GAL in the human urinary bladder. | lld:pubmed |
| pubmed-article:2446889 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2446889 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2446889 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2446889 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2446889 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2446889 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2446889 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2446889 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2446889 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:2446889 | pubmed:issn | 0014-2999 | lld:pubmed |
| pubmed-article:2446889 | pubmed:author | pubmed-author:MeliAA | lld:pubmed |
| pubmed-article:2446889 | pubmed:author | pubmed-author:TuriniDD | lld:pubmed |
| pubmed-article:2446889 | pubmed:author | pubmed-author:MaggiC ACA | lld:pubmed |
| pubmed-article:2446889 | pubmed:author | pubmed-author:SanticioliPP | lld:pubmed |
| pubmed-article:2446889 | pubmed:author | pubmed-author:PatacchiniRR | lld:pubmed |
| pubmed-article:2446889 | pubmed:author | pubmed-author:GiulianiSS | lld:pubmed |
| pubmed-article:2446889 | pubmed:author | pubmed-author:BarbantiGG | lld:pubmed |
| pubmed-article:2446889 | pubmed:author | pubmed-author:BenefortiPP | lld:pubmed |
| pubmed-article:2446889 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2446889 | pubmed:day | 3 | lld:pubmed |
| pubmed-article:2446889 | pubmed:volume | 143 | lld:pubmed |
| pubmed-article:2446889 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2446889 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2446889 | pubmed:pagination | 135-7 | lld:pubmed |
| pubmed-article:2446889 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2446889 | pubmed:meshHeading | pubmed-meshheading:2446889-... | lld:pubmed |
| pubmed-article:2446889 | pubmed:meshHeading | pubmed-meshheading:2446889-... | lld:pubmed |
| pubmed-article:2446889 | pubmed:meshHeading | pubmed-meshheading:2446889-... | lld:pubmed |
| pubmed-article:2446889 | pubmed:meshHeading | pubmed-meshheading:2446889-... | lld:pubmed |
| pubmed-article:2446889 | pubmed:meshHeading | pubmed-meshheading:2446889-... | lld:pubmed |
| pubmed-article:2446889 | pubmed:meshHeading | pubmed-meshheading:2446889-... | lld:pubmed |
| pubmed-article:2446889 | pubmed:meshHeading | pubmed-meshheading:2446889-... | lld:pubmed |
| pubmed-article:2446889 | pubmed:meshHeading | pubmed-meshheading:2446889-... | lld:pubmed |
| pubmed-article:2446889 | pubmed:meshHeading | pubmed-meshheading:2446889-... | lld:pubmed |
| pubmed-article:2446889 | pubmed:meshHeading | pubmed-meshheading:2446889-... | lld:pubmed |
| pubmed-article:2446889 | pubmed:meshHeading | pubmed-meshheading:2446889-... | lld:pubmed |
| pubmed-article:2446889 | pubmed:meshHeading | pubmed-meshheading:2446889-... | lld:pubmed |
| pubmed-article:2446889 | pubmed:meshHeading | pubmed-meshheading:2446889-... | lld:pubmed |
| pubmed-article:2446889 | pubmed:year | 1987 | lld:pubmed |
| pubmed-article:2446889 | pubmed:articleTitle | Galanin: a potent modulator of excitatory neurotransmission in the human urinary bladder. | lld:pubmed |
| pubmed-article:2446889 | pubmed:affiliation | Pharmacology Department, A. Menarini Pharmaceuticals, Florence, Italy. | lld:pubmed |
| pubmed-article:2446889 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2446889 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:51083 | entrezgene:pubmed | pubmed-article:2446889 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2446889 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2446889 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2446889 | lld:pubmed |
